Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/31264
Title: The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART
Authors: Van Leth, F
Andrews, S
Grinsztejn, Beatriz
Wilkins, E
Lazanas, M K
Lange, J M A
Montaner, J
2NN study group
Affilliation: University of Amsterdam. Department of Internal Medicine. Academic Medical Center. International Antiviral Therapy Evaluation Center. the Netherlands.
Brooklyn Medical Center. Cape Town, South Africa.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
North Manchester General Hospital. Manchester, UK.
Hellenic Red Cross General Hospital. Athens, Greece.
University of Amsterdam. Department of Internal Medicine. Academic Medical Center. International Antiviral Therapy Evaluation Center. the Netherlands.
University of British Columbia. St. Paul’s Hospital. Vancouver, Canada.
Abstract: A substantial number of patients start their first-line antiretroviral therapy at an advanced stage of an HIV-1 infection. Potential differences between specific drug regimens in antiviral efficacy and safety in these patients are of major importance.
Keywords: HIV-1
CD4
Viral load
Disease stage
2NN
Issue Date: 2005
Publisher: Lippincott Williams & Wilkins
Citation: VAN LETH, F. et al. The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART. AIDS, v. 19, n. 5, p. 463-471, 2005.
DOI: 10.1097/01.aids.0000162334.12815.5b
ISSN: 0269-9370
Copyright: restricted access
Appears in Collections:INI - Artigos de Periódicos

Files in This Item:
File Description SizeFormat 
The effect of baseline_Beatriz_Grinsztejn_INI_Lapclin-AIDS_2005.pdf162.68 kBAdobe PDF    Request a copy


FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.